Serum NGAL concentrations are higher in patients with decreased kidney function than in healthy controls; however, there is debate over the variations in serum NGAL levels between patients with acute kidney injury (AKI) and those with CKD. This evidence concerns the gene LCN2 and acute kidney injury.